.STUDY FEATURE.06 August 2024.
A big randomized measured test with cisgender females highlights the problems of obedience to an everyday oral preexposure prevention regiment as well as shows that twice-yearly injection of lenacapavir can preserve reliable HIV avoidance amounts over 6 months.